ArticleVaccine2019
The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania.
Article in Vaccine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
64 citing papers in PubMed, 113 citations in OpenAlex.
- Pre-exposure prophylaxis as a complementary vaccination strategy to reduce rabies in Kerala, India: a cost-effectiveness modelling study.The Lancet regional health. Southeast Asia · 2026Article
- Cost-utility analysis of pre-exposure prophylaxis rabies vaccine in 5-year-old children in Thailand.BMJ global health · 2026Article
- Completion of rabies post-exposure prophylaxis in Ouagadougou, Burkina Faso, 2021-2023: A cross-sectional analysis of routine data.PLoS neglected tropical diseases · 2026Article
- Effects of a school-based programme on learners' rabies awareness in Machakos, Kenya.Epidemiology and infection · 2026Article
- Comparative effectiveness and cost-effectiveness of policies for provisioning rabies post-exposure vaccines.Vaccine · 2026Article
- Experiences of piloting integrated bite case management in Zaria Metropolis, Nigeria.Frontiers in tropical diseases · 2026Article
- Exploring the social and organizational factors influencing dog bites: a qualitative study.BMC public health · 2026Article
- Working towards a single-dose vaccine for rabies post-exposure prophylaxis.Future virology · 2026Article
- Healthcare accessibility to rabies post-exposure prophylaxis in rural Kenya: implications for vaccine placement and travel time.Frontiers in microbiology · 2026Article
- Practitioner's perspectives on access to Rabies Post-Exposure Prophylaxis in Tanzania: A mixed-methods and theoretically-informed study to inform policy and practice.PLOS global public health · 2026Article
- Barriers to dog bite case management and dog rabies vaccination in Soroti district, Uganda.Frontiers in veterinary science · 2026Article
- Rabies outbreak in Lefeisa town, Somali region, Ethiopia: A report on epidemiological trends and one health implications.One health (Amsterdam, Netherlands) · 2025Article
- Drivers of rabies post-exposure prophylaxis noncompletion in Cambodia, 2019 to 2022.PLoS neglected tropical diseases · 2025Article
- Two-leaves and many bites: Profiling dog-bites and adherence to rabies prophylaxis in tea-estate communities of Udalguri District, Assam, India.PLoS neglected tropical diseases · 2025Article
- Access to Rabies Post-Exposure Prophylaxis in Tanzania: A mixed-methods and theoretically-informed study to inform policy and practise.medRxiv : the preprint server for health sciences · 2025Article
- Exploring Global Strategies to Combat Rabies: Addressing Limitations and Enhancing Effectiveness.Veterinary medicine and science · 2025Review
- Availability of anti-rabies vaccine and rabies immunoglobulin in Indian health facilities: a nationwide cross-sectional health facility survey.The Lancet regional health. Southeast Asia · 2025Article
- Deep mutational scanning of rabies glycoprotein defines mutational constraint and antibody-escape mutations.Cell host & microbe · 2025Article
- Exploring one health-based strategies for rabies elimination: Overview and future prospects.PLoS neglected tropical diseases · 2025Review
- Improved effectiveness of vaccination campaigns against rabies by reducing spatial heterogeneity in coverage.PLoS biology · 2025Article
4 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 4 institutions in 2 countries.
Funding
Abstract
backgroundRabies is preventable through prompt administration of post-exposure prophylaxis (PEP) to exposed persons, but PEP access is limited in many rabies-endemic countries. We investigated how access to PEP can be improved to better prevent human rabies.
methodsUsing data from different settings in Tanzania, including contact tracing (2,367 probable rabies exposures identified) and large-scale mobile phone-based surveillance (24,999 patient records), we estimated the incidence of rabies exposures and bite-injuries, and examined health seeking and health outcomes in relation to PEP access. We used surveys and qualitative interviews with stakeholders within the health system to further characterise PEP supply and triangulate these findings.
resultsIncidence of bite-injury patients was related to dog population sizes, with higher incidence in districts with lower human:dog ratios and urban centres. A substantial percentage (25%) of probable rabies exposures did not seek care due to costs and limited appreciation of risk. Upon seeking care a further 15% of probable rabies exposed persons did not obtain PEP due to shortages, cost barriers or misadvice. Of those that initiated PEP, 46% did not complete the course. If no PEP was administered, the risk of developing rabies following a probable rabies exposure was high (0.165), with bites to the head carrying most risk. Decentralized and free PEP increased the probability that patients received PEP and reduced delays in initiating PEP. No major difficulties were encountered by health workers whilst switching to dose-sparing ID administration of PEP. Health infrastructure also includes sufficient cold chain capacity to support improved PEP provision. However, high costs to governments and patients currently limits the supply chain and PEP access. The cost barrier was exacerbated by decentralization of budgets, with priority given to purchase of cheaper medicines for other conditions. Reactive procurement resulted in limited and unresponsive PEP supply, increasing costs and risks to bite victims.
conclusionPEP access could be improved and rabies deaths reduced through ring-fenced procurement, switching to dose-sparing ID regimens and free provision of PEP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.